Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danaher
Washington, DC, United Statesdanaher.com ↗
- Ownership
- Public · DHR
- Employees
- ~80000
- Development stage
- Commercial
01
Overview
Danaher operates as a global leader in life sciences and diagnostics with commercialized products spanning bioprocessing equipment/supplies, molecular/genomic/proteomic research tools, clinical diagnostic instruments/reagents/software. The company does not develop therapeutics but enables R&D and manufacturing across the healthcare industry through its portfolio companies. Recent acquisitions include Abcam ($5.7B in 2023), expanding their proteomics capabilities. Other major acquisitions include Cytiva ($21.4B in 2020), Pall ($13.8B in 2015), Cepheid ($4B in 2016), Beckman Coulter ($8.8B in 2011). The company has spun off non-core businesses to focus on healthcare/life science markets. No direct clinical results as it does not develop drugs or therapies.
- Therapeutic areas
- OncologyImmunologyRare DiseasesOtherCardiovascularNeurologyInfectious Diseases
- Modalities
- DeviceDiagnostic technologyBiologic (via subsidiaries and platforms)Reagent/antibody toolsGenomics toolsSmall molecule (enabling technologies for discovery/manufacturing)
- Industry
- Molecular Diagnostics
02
Partnerships
Numerous collaborations with academic institutions/pharma/biotech for supply of instruments/reagents; specific partnerships are typically at the subsidiary level.
Beyond the preview
Go deeper on Danaher.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Danaher.